苑东生物跌2.09%，成交额7644.89万元，主力资金净流出276.58万元

Group 1 - The core viewpoint of the news is that Yuan Dong Bio has experienced a significant stock price increase of 97.60% this year, despite a recent decline of 2.09% in its stock price [1] - As of December 29, the stock price is reported at 58.70 yuan per share, with a total market capitalization of 10.362 billion yuan [1] - The company has a diverse revenue structure, with 78.75% of its main business income coming from formulation sales, 9.22% from raw material sales, and smaller contributions from technology services and CMO/CDMO [1] Group 2 - As of September 30, the number of shareholders for Yuan Dong Bio has increased by 18.67% to 6,482, while the average circulating shares per person decreased by 15.74% to 27,234 shares [2] - For the period from January to September 2025, the company reported a revenue of 1.019 billion yuan, a year-on-year decrease of 2.00%, while the net profit attributable to the parent company was 220 million yuan, reflecting a year-on-year growth of 1.45% [2] - The company has distributed a total of 341 million yuan in dividends since its A-share listing, with 212 million yuan distributed over the past three years [3]